Aptevo Therapeutics (APVO) Receivables - Net (2016 - 2019)
Historic Receivables - Net for Aptevo Therapeutics (APVO) over the last 5 years, with Q4 2019 value amounting to $7.0 million.
- Aptevo Therapeutics' Receivables - Net rose 3452.11% to $7.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was $7.0 million, marking a year-over-year increase of 3452.11%. This contributed to the annual value of $7.0 million for FY2019, which is 3452.11% up from last year.
- Per Aptevo Therapeutics' latest filing, its Receivables - Net stood at $7.0 million for Q4 2019, which was up 3452.11% from $7.9 million recorded in Q3 2019.
- In the past 5 years, Aptevo Therapeutics' Receivables - Net registered a high of $8.5 million during Q2 2016, and its lowest value of $307000.0 during Q4 2016.
- Its 5-year average for Receivables - Net is $4.8 million, with a median of $5.5 million in 2018.
- Its Receivables - Net has fluctuated over the past 5 years, first crashed by 9524.47% in 2016, then soared by 107462.12% in 2018.
- Aptevo Therapeutics' Receivables - Net (Quarter) stood at $6.5 million in 2015, then tumbled by 95.24% to $307000.0 in 2016, then skyrocketed by 597.39% to $2.1 million in 2017, then soared by 143.81% to $5.2 million in 2018, then surged by 34.52% to $7.0 million in 2019.
- Its Receivables - Net stands at $7.0 million for Q4 2019, versus $7.9 million for Q3 2019 and $7.4 million for Q2 2019.